HRMY
Price
$37.36
Change
+$0.47 (+1.27%)
Updated
Sep 2, 10:34 AM (EDT)
Capitalization
2.12B
63 days until earnings call
SPHDF
Price
$18.40
Change
+$3.65 (+24.75%)
Updated
Jul 28 closing price
Capitalization
222.58M
Interact to see
Advertisement

HRMY vs SPHDF

Header iconHRMY vs SPHDF Comparison
Open Charts HRMY vs SPHDFBanner chart's image
Harmony Biosciences Holdings
Price$37.36
Change+$0.47 (+1.27%)
Volume$200
Capitalization2.12B
Santhera Pharmaceuticals Holdings
Price$18.40
Change+$3.65 (+24.75%)
Volume$600
Capitalization222.58M
HRMY vs SPHDF Comparison Chart in %
Loading...
HRMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPHDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HRMY vs. SPHDF commentary
Sep 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRMY is a StrongBuy and SPHDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 02, 2025
Stock price -- (HRMY: $36.89 vs. SPHDF: $18.40)
Brand notoriety: HRMY and SPHDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HRMY: 85% vs. SPHDF: 133%
Market capitalization -- HRMY: $2.12B vs. SPHDF: $222.58M
HRMY [@Biotechnology] is valued at $2.12B. SPHDF’s [@Biotechnology] market capitalization is $222.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HRMY’s FA Score shows that 0 FA rating(s) are green whileSPHDF’s FA Score has 1 green FA rating(s).

  • HRMY’s FA Score: 0 green, 5 red.
  • SPHDF’s FA Score: 1 green, 4 red.
According to our system of comparison, both HRMY and SPHDF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HRMY’s TA Score shows that 6 TA indicator(s) are bullish while SPHDF’s TA Score has 4 bullish TA indicator(s).

  • HRMY’s TA Score: 6 bullish, 3 bearish.
  • SPHDF’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, HRMY is a better buy in the short-term than SPHDF.

Price Growth

HRMY (@Biotechnology) experienced а -2.56% price change this week, while SPHDF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.70%. For the same industry, the average monthly price growth was +20.59%, and the average quarterly price growth was +30.71%.

Reported Earning Dates

HRMY is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Biotechnology (-0.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HRMY($2.12B) has a higher market cap than SPHDF($223M). HRMY has higher P/E ratio than SPHDF: HRMY (11.90) vs SPHDF (2.52). SPHDF YTD gains are higher at: 95.329 vs. HRMY (7.207).
HRMYSPHDFHRMY / SPHDF
Capitalization2.12B223M952%
EBITDA265MN/A-
Gain YTD7.20795.3298%
P/E Ratio11.902.52472%
Revenue773MN/A-
Total Cash565MN/A-
Total Debt172MN/A-
FUNDAMENTALS RATINGS
SPHDF: Fundamental Ratings
SPHDF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
11
SEASONALITY SCORE
1..100
22

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HRMYSPHDF
RSI
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 7 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
74%
Bullish Trend 5 days ago
21%
Momentum
ODDS (%)
Bullish Trend 5 days ago
72%
N/A
MACD
ODDS (%)
Bullish Trend 5 days ago
73%
Bearish Trend 5 days ago
65%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
75%
Bullish Trend 5 days ago
12%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
73%
Bullish Trend 5 days ago
14%
Advances
ODDS (%)
Bullish Trend 12 days ago
76%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
76%
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 5 days ago
73%
Bullish Trend 5 days ago
11%
View a ticker or compare two or three
Interact to see
Advertisement
HRMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPHDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIMVX28.87-0.03
-0.10%
Fidelity Mid Cap Value Index
MRGGX43.97-0.18
-0.41%
MFS Core Equity R1
IHSVX30.09-0.21
-0.69%
Hartford Small Company R6
ADGAX25.69-0.18
-0.70%
AB Core Opportunities A
JMIGX31.16-0.49
-1.55%
Jacob Discovery Fd Instl

HRMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRMY has been loosely correlated with GSGTF. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if HRMY jumps, then GSGTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRMY
1D Price
Change %
HRMY100%
-2.84%
GSGTF - HRMY
44%
Loosely correlated
N/A
ANAB - HRMY
36%
Loosely correlated
+0.99%
SPHDF - HRMY
34%
Loosely correlated
N/A
LGND - HRMY
31%
Poorly correlated
+1.09%
GERN - HRMY
30%
Poorly correlated
-2.10%
More

SPHDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPHDF has been closely correlated with GYRE. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if SPHDF jumps, then GYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPHDF
1D Price
Change %
SPHDF100%
N/A
GYRE - SPHDF
82%
Closely correlated
-6.52%
HRMY - SPHDF
37%
Loosely correlated
-2.84%
SPRC - SPHDF
34%
Loosely correlated
-18.81%
INM - SPHDF
33%
Poorly correlated
+1.83%
RVMD - SPHDF
33%
Poorly correlated
-0.93%
More